Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where N. Uemura is active.

Publication


Featured researches published by N. Uemura.


Clinical Pharmacology & Therapeutics | 2004

Delayed disposition of cocaine in sweat patches and in skin blister: cocaine may migrate from plasma to sweat patches via interstitial fluid

N. Uemura; M. R. Harkey; Rajneesh P. Nath; G. L. Henderson; John Mendelson; Reese T. Jones

Sweat patch analysis is extensively used for drug abuse monitoring. The present study investigates how cocaine migrates to sweat patches. In the cumulative collection model, the drug absorption rate in patches should be proportional to the drug concentration in the preceding disposition compartment if drug back‐transfer is negligible. Therefore, we measured the slopes of cocaine concentration curves in patches as a marker for absorption rate (into patches) after a single dose of cocaine‐d5 (1mg/kg over 60 min) in healthy cocaine users (n=5). Patches were placed on the back of subjects prior to drug administration and removed at 0–72 hr postdose. Blood and interstitial fluid (skin blister fluid) were collected up to 72 hr. Patch cocaine levels showed semi‐cumulative collection with peaks between 8 and 48 hr. Cocaine levels in plasma and interstitial fluid peaked at 1.0±0 and 5.3±0.6 hours postdose, respectively, suggesting a delayed cocaine disposition in the interstitial fluid. Similarly, patch cocaine absorption was delayed with rate peaks at 4.3±2.9 hr postdose. Tmax for plasma benzoylecgonine (BE) was 5.0±2.4 hr. BE also showed a delayed peak in the interstitial fluid at 11.3±11.0 hr post, and the highest BE absorption in patches was observed in a similar time range of 12.4±4.9 hr. Cocaine and its metabolite migrate into patches in a time period that coincides with Tmax in interstitial fluid. Cocaine seems to travel from plasma to sweat patches via interstitial fluid.


Clinical Pharmacology & Therapeutics | 2005

Pharmacokinetics of intravenous d- and l-methamphetamine in healthy volunteers

N. Uemura; Debra S. Harris; Rajneesh P. Nath; E. Fernandez; Peyton Jacob; Everhart Et; Reese T. Jones; John Mendelson

Methamphetamine has a chiral structure. The aim of the present study was to assess the pharmacokinetics of methamphetamine enantiomers in humans.


Clinical Pharmacology & Therapeutics | 2003

Three Day 12-Hour Cocaine Infusion Produces Tolerance in Cardiovascular and Subjective Effects, But Does Not Alter Cocaine Self-Administration Behavior in Humans

N. Uemura; A.P. Manari; Rajneesh P. Nath; Debra S. Harris; Reese T. Jones; John Mendelson

Clinical Pharmacology & Therapeutics (2003) 73, P91–P91; doi:


Clinical Pharmacology & Therapeutics | 2003

The Cardiovascular Effects of D- and L-Methamphetamine

John Mendelson; Elyse Foster; E. Ryan; N. Uemura; Rajneesh P. Nath; Reese T. Jones

Clinical Pharmacology & Therapeutics (2003) 73, P36–P36; doi:


Clinical Pharmacology & Therapeutics | 2003

Sustained 3-Day Intravenous Cocaine Exposure Decreases Appetite and Hunger But Does Not Alter Food Intake Patterns in Cocaine-Dependent Volunteers

A.P. Manari; N. Uemura; Rajneesh P. Nath; Debra S. Harris; Reese T. Jones; John Mendelson

Clinical Pharmacology & Therapeutics (2003) 73, P35–P35; doi:


Journal of Analytical Toxicology | 2004

Cocaine Levels in Sweat Collection Patches Vary by Location of Patch Placement and Decline Over Time

N. Uemura; Rajneesh P. Nath; Martha R. Harkey; Gary L. Henderson; John Mendelson; Reese T. Jones


Journal of Analytical Toxicology | 2002

Disposition of Cocaine in Skin, Interstitial Fluid, Sebum, and Stratum Corneum

Laeben Lester; N. Uemura; John I. Ademola; Martha R. Harkey; Rajneesh P. Nath; Seong Jin Kim; Elena Jerschow; Gary L. Henderson; John Mendelson; Reese T. Jones


Quality Assurance Journal | 2005

Overseas GCP inspections by the Japanese Regulatory Agency: a systematic review of 13 cases (1998–2003)

Kiyomi Hirayama; Naohisa Fukuda; Hitoshi Satoh; Katsumi Itoh; Kiyoshi Chiba; Yutaka Nakae; Masayuki Takezawa; Kuniko Gotoh; N. Uemura


Clinical Pharmacology & Therapeutics | 2001

Cocaine levels in sweat patches decline over time

N. Uemura; L. Lester; Rajneesh P. Nath; John Mendelson; M. R. Harkey; G. L. Henderson; Reese T. Jones


Clinical Pharmacology & Therapeutics | 2001

Pharmacologic interactions between transdermal selegiline and cocaine

John Mendelson; A. S. Dearborn; N. Uemura; L. Lester; N. Chiang; Peyton Jacob; Reese T. Jones

Collaboration


Dive into the N. Uemura's collaboration.

Top Co-Authors

Avatar

John Mendelson

California Pacific Medical Center

View shared research outputs
Top Co-Authors

Avatar

Reese T. Jones

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A.P. Manari

University of California

View shared research outputs
Top Co-Authors

Avatar

E. Fernandez

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L. Lester

University of California

View shared research outputs
Top Co-Authors

Avatar

M. R. Harkey

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge